Strategies for improved formulation and delivery of DNA vaccines to veterinary target species

Immunological Reviews

Volumn 199, Issue , 2004, Pages 113-125

  Van Drunen Littel van Den Hurk, Sylvia ^a   Babiuk, Shawn L ^a   Babiuk, Lorne A ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM SALT; CHOLERA TOXIN; CYTOKINE; DIMETHYL SULFOXIDE; DIMETHYLDIOCTADECYLAMMONIUM BROMIDE; DNA VACCINE; ESCHERICHIA COLI ENTEROTOXIN; IMMUNOLOGICAL ADJUVANT; POLYGLACTIN; POVIDONE;

ANTIGEN PRESENTING CELL; CPG ISLAND; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ELECTROPORATION; GENE EXPRESSION; GENE GUN; GENE TARGETING; GENETIC TRANSFECTION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; INFESTATION; JET INJECTION; LIVESTOCK; NONHUMAN; PLASMID; PRIORITY JOURNAL; REVIEW; SEROLOGY; STATISTICAL SIGNIFICANCE; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMAL DISEASES; ANIMALS; CYTOKINES; PLASMIDS; VACCINATION; VACCINES, DNA;

EID: 2942592575     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0105-2896.2004.00140.x     Document Type: Review

References (94)

1. Willadsen P. Novel vaccines for ectoparasites. Vet Parasitol 1997;71:209-222.
2. Ulmer JB, et al. Enhancement of DNA vaccine potency using conventional aluminum adjuvants. Vaccine 1999;18:18-28.
3. Fischer L, Minke J, Dufay N, Baudu P, Audonnet JC. Rabies DNA vaccine in the horse: strategies to improve serological responses. Vaccine 2003;21:4593-4596.
4. van Rooij EM, et al. Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant. J Virol 2002;76:10540-10545.
5. Suarez DL, Schultz-Cherry S. The effect of eukaryotic expression vectors and adjuvants on DNA vaccines in chickens using an avian influenza model. Avian Dis 2000;44:861-868.
6. Heckert RA, Elankumaran S, Oshop GL, Vakharia VN. A novel transcutaneous plasmid-dimethylsulfoxide delivery technique for avian nucleic acid immunization. Vet Immunol Immunopathol 2002;89:67-81.
7. Arrington J, et al. Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines. J Virol 2002;76:4536-4546.
8. Soboll G, et al. Mucosal co-administration of cholera toxin and influenza virus hemagglutinin-DNA in ponies generates a local IgA response. Vaccine 2003;21:3081-3092.
9. Fischer L, Tronel JP, Minke J, Barzu S, Baudu P, Audonnet JC. Vaccination of puppies with a lipid-formulated plasmid vaccine protects against a severe canine distemper virus challenge. Vaccine 2003;21:1099-1102.
10. Anwer K, et al. Synergistic effect of formulated plasmid and needle-free injection for genetic vaccines. Pharm Res 1999;16:889-895.
11. O'Hagan D, et al. Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines. J Virol 2001;75:9037-9043.
12. Otten G, et al. Induction of broad and potent anti-human immunodeficiency virus immune responses in rhesus macaques by priming with a DNA vaccine and boosting with protein-adsorbed polylactide coglycolide microparticles. J Virol 2003;77:6087-6092.
13. Loehr BI, et al. Suppository-mediated DNA immunization induces mucosal immunity against bovine herpesvirus-1 in cattle. Virology 2001;289:327-333.
14. Krieg AM, Yi AK, Hartmann G, Mechanisms and therapeutic applications of immune stimulatory CpG DNA. Pharmacol Ther 1999;84:113-120.
15. Davis HL, et al. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen [published erratum appears in J Immunol 1999; 162: 3103]. J Immunol 1998;160:870-876.
16. Klinman DM, Barnhart KM, Conover J. CpG motifs as immune adjuvants. Vaccine 1999;17:19-25.
17. Klinman DM, Ishii KJ, Verthelyi D. CpG DNA augments the immunogenicity of plasmid DNA vaccines. Curr Top Microbiol Immunol 2000;247:131-142.
18. Zhou X, Zheng I, Liu L, Xiang L, Yuan Z. T helper 2 immunity to hepatitis B surface antigen primed by gene-gun-mediated DNA vaccination can be shifted towards T helper 1 immunity by co-delivery of CpG motif-containing oligodeoxynudeotides. Scand J Immunol 2003;58:350-357.
19. Krieg AM, Yi A-K, Schorr J, Davis HL. The role of CpG dinucleotides in DNA vaccines. Trends Microbiol 1998;6:23-27.
20. Cantlon JD, Gordy PW, Bowen RA. Immune responses in mice, cattle and horses to a DNA vaccine for vesicular stomatitis. Vaccine 2000;18:2368-2374.
21. Leutenegger CM, et al. Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif. J Virol 2000;74:10447-10457.
22. Pontarollo RA, Babiuk LA, Hecker R, Van Drunen Littel-Van Den Hurk S. Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors. J Gen Virol 2002;83:2973-2981.
23. Wong HT, Cheng SC, Sin FW, Chan EW, Sheng ZT, Xie Y. A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2. Vaccine 2002;20:2641-2647.
24. Larsen DL, Olsen CW. Effects of DNA dose, route of vaccination, and coadministration of porcine interleukin-6 DNA on results of DNA vaccination against influenza virus infection in pigs. Am J Vet Res 2002;63:653-659.
25. Somasundaram C, et al. Enhanced protective response and immuno-adjuvant effects of porcine GM-CSF on DNA vaccination of pigs against Aujeszky's disease virus. Vet Immunol Immunopathol 1999;70:277-287.
26. Cedillo-Barron L, et al. Immunogenicity of plasmids encoding T and B cell epitopes of foot-and-mouth disease virus (FMDV) in swine. Vaccine 2003;21:4261-4269.
27. Scheerlinck JP, et al. The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy. Vaccine 2001;19:4053-4060.
28. Giese M, et al. Stable and long-lasting immune response in horses after DNA vaccination against equine arteritis virus. Virus Genes 2002;25:159-167.
29. Dunham SP, et al. Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18. Vaccine 2002;20:1483-1496.
30. Hanlon L, et al. Feline leukemia virus DNA vaccine efficacy is enhanced by co-administration with interleukin-12 (IL-12) and IL-18 expression vectors. J Virol 2001;75:8424-8433.
31. Glansbeek HL, et al. Adverse effects of feline IL-12 during DNA vaccination against feline infectious peritonitis virus. J Gen Virol 2002;83:1-10.
32. Min W, Lillehoj HS, Burnside J, Weining KC, Staeheli P, Zhu JJ. Adjuvant effects of IL-1beta, IL-2, IL-8, IL-15, IFN-alpha, IFN-gamma TGF-beta4 and lymphotactin on DNA vaccination against Eimeria acervulina. Vaccine 2001;20:267-274.
33. Kim JJ, et al. Antigen-specific humoral and cellular immune responses can be modulated in rhesus macaques through the use of IFN-gamma, IL-12, or IL-18 gene adjuvants. J Med Primatol 1999;28:214-223.
34. Kim JJ, et al. Modulation of antigen-specific humoral responses in rhesus macaques by using cytokine cDNAs as DNA vaccine adjuvants. J Virol 2000;74:3427-3429.
35. Kim JJ, Yang JS, Manson KH, Weiner DB. Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-gamma, or IL-4 gene adjuvants. Vaccine 2001;19:2496-2505.
36. Kumar S, et al. A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-gamma and cytotoxic T cell responses in rhesus monkeys: immunostimulatory effects of granulocyte macrophage-colony stimulating factor. Immunol Lett 2002;81:13-24.
37. + T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF. J Immunol 2002;168:562-568.
38. Lemieux P. Technological advances to increase immunogenicity of DNA vaccines. Expert Rev Vaccines 2002;1:85-93.
39. Chaplin PJ, et al. Targeting improves the efficacy of a DNA vaccine against Corynebacterium pseudotuberculosis in sheep. Infect Immun 1999;67:6434-6438.
40. Drew DR, Boyle JS, Lew AM, Lightowlers MW, Chaplin PJ, Strugnell RA. The comparative efficacy of CTLA-4 and 1-selectin targeted DNA vaccines in mice and sheep. Vaccine 2001;19:4417-4428.
41. Tachedjian M, et al. Gene gun immunization in a preclinical model is enhanced by B7 targeting. Vaccine 2003;21:2900-2905.
42. Shkreta L, Talbot BG, Lacasse P. Optimization of DNA vaccination immune responses in dairy cows: effect of injection site and the targeting efficacy of antigen-bCTLA-4 complex. Vaccine 2003;21:2372-2382.
43. Manoj S, Griebel PJ, Babiuk LA, van Drunen Littel-van den Hurk S. Targeting with bovine CD154 enhances humoral immune responses induced by a DNA vaccine in sheep. J Immunol 2003;170:989-996.
44. jr. DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 1996;2:1122-1128.
45. jr. DNA immunization targeting the skin: molecular control of adaptive immunity. J Invest Dermatol 1998;111:183-188.
46. Feltquate DM, Heaney S, Webster RG, Robinson HL. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol 1997;158:2278-2284.
47. Prayaga SK, Ford MJ, Haynes JR. Manipulation of HIV-1 gp120-specific immune responses elicited via gene gun-based DNA immunization. Vaccine 1997;15:1349-1352.
48. Weiss R, Scheiblhofer S, Freund J, Ferreira F, Livey I, Thalhamer J. Gene gun bombardment with gold particles displays a particular Th2-promoting signal that over-rules the Th1-inducing effect of immunostimulatory CpG motifs in DNA vaccines. Vaccine 2002;20:3148-3154.
49. Babiuk S, et al. Needle-free topical electroporation improves gene expression from plasmids administered in porcine skin. Mol Ther 2004;8:992-999.
50. Babiuk S, Baca-Estrada ME, Pontarollo R, Foldvari M. Topical delivery of plasmid DNA using biphasic lipid vesicles (Biphasix). J Pharm Pharmacol 2002;54:1609-1614.
51. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci USA 1993;90:11478-11482.
52. Braun RP, Babiuk LA, Loehr BI, van Drunen Littel-van den Hurk S. Particle-mediated DNA immunization of cattle confers long-lasting immunity against bovine herpesvirus-1. Virology 1999;265:46-56.
53. Loehr BI, Willson P, Babiuk LA, van Drunen Littel-van den Hurk S. Gene gun-mediated DNA immunization primes development of mucosal immunity against bovine herpesvirus 1 in cattle. J Virol 2000;74:6077-6086.
54. De Rose R, et al. Efficacy of DNA vaccination by different routes of immunization in sheep. Vet Immunol Immunopathol 2002;90:55-63.
55. Lodmell DL, Parnell MJ, Bailey JR, Ewalt LC, Hanlon CA. Rabies DNA vaccination of non-human primates: post-exposure studies using gene gun methodology that accelerates induction of neutralizing antibody and enhances neutralizing antibody titers. Vaccine 2002;20:2221-2228.
56. Bleasdale HN. B.C.G. vaccination by jet injection. Tubercle 1965;46:417-419.
57. Haensler J, et al. Intradermal DNA immunization by using jet-injectors in mice and monkeys. Vaccine 1999;17:628-638.
58. Furth PA, Shamay A, Hennighlusen L. Gene transfer into mammalian cells by jet injection. Hybridoma 1995;14:149-152.
59. Sawamura D, et al. In vivo gene introduction into keratinocytes using jet injection. Gene Ther 1999;6:1785-1787.
60. Walther W, Stein U, Fichtner I, Malcherek L, Lemm M, Schlag PM. Non-viral in vivo gene delivery into tumors using a novel low volume jet-injection technology. Gene Ther 2001;8:173-180.
61. Mumper RJ, Cui Z. Genetic immunization by jet injection of targeted pDNA-coated nanoparticles. Methods 2003;31:255-262.
62. Dileo J, TE, Chesnoy S, Huang L. Gene transfer to subdermal tissues via a new gene gun design. Hum Gene Ther 2003;14:79-87.
63. Chang DC, Reese TS. Changes in membrane structure induced by electroporation as revealed by rapid-freezing electron microscopy. Biophys J 1990;58:1-12.
64. Morgan WF, Day JP. The introduction of proteins into mammalian cells by electroporation. Methods Mol Biol 1995;48:63-71.
65. DeBruin KA, Krassowska W. Modeling electroporation in a single cell. I. Effects of field strength and rest potential. Biophys J 1999;77:1213-1224.
66. Bier M, Hammer SM, Canaday DJ, Lee RC. Kinetics of sealing for transient electropores in isolated mammalian skeletal muscle cells. Bioelectromagnetics 1999;20:194-201.
67. Saulis G. Pore disappearance in a cell after electroporation: theoretical simulation and comparison with experiments. Biophys J 1997;73:1299-1309.
68. Aihara H, Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998;16:867-870.
69. Mathiesen I. Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther 1999;6:508-514.
70. Glasspool-Malone J, Somiari S, Drabick JJ, Malone RW. Efficient nonviral cutaneous transfection. Mol Ther 2000;2:140-146.
71. Dean DA, Machado-Aranda D, Blair-Parks K, Yeldandi AV, Young JL. Electroporation as a method for high-level nonviral gene transfer to the lung. Gene Ther 2003;18:1608-1615.
72. Blair-Parks K, Weston BC, Dean DA. High-level gene transfer to the cornea using electroporation. J Gene Med 2002;4:92-100.
73. Lin CR, et al. Electroporation for direct spinal gene transfer in rats. Neurosci Lett 2002;317:1-4.
74. Nakamura H, Funahashi J. Introduction of DNA into chick embryos by in ovo electroporation. Methods 2001;24:43-48.
75. Zaharoff DA, Barr RC, Li CY, Yuan F. Electromobility of plasmid DNA in tumor tissues during electric field-mediated gene delivery. Gene Ther 2002;9:1286-1290.
76. Dupuis M, et al. Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice. J Immunol 2000;165:2850-2858.
77. Widera G, et al. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 2000;164:4635-4640.
78. Zucchelli S, et al. Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer. J Virol 2000;74:11598-11607.
79. Babiuk S, et al. Electroporation improves the efficacy of DNA vaccines in large animals. Vaccine 2002;20:3399.
80. Tollefsen S, et al. DNA injection in combination with electroporation: a novel method for vaccination of farmed ruminants. Scand J Immunol 2003;57:229-238.
81. Drabick JJ, Glasspool-Malone J, King A, Malone RW. Cutaneous transfection and immune responses to intradermal DNA vaccination are significantly enhanced by in vivo electropermeabilization. Mol Ther 2001;2:249-255.
82. Zhang L, Nolan E, Kreitschitz S, Rabussay DP. Enhanced delivery of naked DNA to the skin by non-invasive in vivo electroporation. Biochim Biophys Acta 2002;1572:1-9.
83. Babiuk LA, Pontarollo R, Babiuk S, Loehr B, van Drunen Littel-van den Hurk S. Induction of immune responses by DNA vaccines in large animals. Vaccine 2003;21:649-658.
84. Benov LC, Antonov PA, Ribarov SR. Oxidative damage of the membrane lipids after electroporation. General Physiol Biophys 1994;13:85-97.
85. Meaking WS, Edgerton J, Wharton CW, Meldrum RA. Electroporation-induced damage in mammalian cell DNA. Biochim Biophys Acta 1995;1264:357-362.
86. Joshi RP, Schoenbach KH. Mechanism for membrane electroporation irreversibility under high-intensity, ultrashort electrical pulse conditions. Phys Rev E Stat Nonlin Soft Matter Phys 2002;66:052901.
87. Lepik D, Jaks V, Kadaja L, Varv S, Maimets T. Electroporation and carrier DNA cause p53 activation, cell cycle arrest, and apoptosis. Anal Biochem 2003;318:52-59.
88. Pazmany T, Murphy SP, Gollnick SO, Brooks SP, Tomasi TB. Activation of multiple transcription factors and fos and jun gene family expression in cells exposed to a single electric pulse. Exp Cell Res 1995;221:103-110.
89. Hartikka J, et al. Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: plasmid dependence of muscle damage and effect of poloxamer 188. Mol Ther 2001;4:407-415.
90. McMahon JM, Signori E, Wells KE, Fazio VM, Wells DJ. Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase - increased expression with reduced muscle damage. Gene Ther 2001;8:1264-1270.
91. Heller LC, Coppola D. Electrically mediated delivery of vector plasmid DNA elicits an antitumor effect. Gene Ther 2002;9:1321-1325.
92. + T cells. J Immunol 2003;171:3379-3384.
93. McAllister DV, et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies. Proc Natl Acad Sci USA 2003;100:13755-13760.
94. Bramson J, Dayball K, Evelegh C, Wan YH, Page D, Smith A. Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines. Gene Ther 2003;3:251-260.